Chinese pediatric guideline for diagnosis,treatment,and prevention of respiratory syncytial virus infection(medical version,2024)
Respiratory syncytial virus(RSV)is one of the most common respiratory pathogens affecting children under 5 years old worldwide,posing a significant threat to their health.In recent years,substantial progress has been made in the field of RSV-related diseases.In order to guide and standardize the clinical decision-making process for RSV diagnosis and treatment and to enhance the prevention and control of RSV infections among children,a guideline development committee has been formed.This committee comprises experts in pediatric respiratory diseases,infectious diseases,neonatology,healthcare,clinical epidemiology,health statistics,virology,evidence-based medicine,and health economics.Following the methodology of constructing clinical practice guidelines,12 clinical questions associating with the detection,diagnosis,treatment,and prevention of RSV-related diseases were proposed from a clinical practice perspective.Through these questions construction,evidence retrieval evaluation,and recommendation opinion discussion,the"Chinese pediatric guideline for diagnosis,treatment,and prevention of respiratory syncytial virus infection(medical version,2024)"were finally formulated to enhance the clinical management and control capabilities of RSV infection related diseases in Chinese children.
NETL
NSTL
万方数据
